| Literature DB >> 33729466 |
Dimitrios Daoussis1, Pantelis Kraniotis2, Foteini Kalofonou3, Haralabos Kalofonos4.
Abstract
Entities:
Keywords: IgG4 related disease; Immune checkpoint inhibitors; anti-PD1; cancer immunotherapy; pembrolizumab; retroperitoneal fibrosis
Year: 2021 PMID: 33729466 DOI: 10.1093/rheumatology/keab264
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580